Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)
Mohamad Mohty(Sorbonne Université), Enric Carreras(Josep Carreras Leukaemia Research Institute), Christina Peters(Cancer Research Institute of the Slovak Academy of Sciences), Mairéad NíChonghaile(Trinity College Dublin), Didier Blaise(Institut Paoli-Calmettes), Fabio Ciceri(Vita-Salute San Raffaele University), Tapani Ruutu(Helsinki University Hospital), Elisabeth Wallhult(Sahlgrenska University Hospital), Peter Bader(Goethe University Frankfurt), J-H Dalle(Délégation Paris 7), Ali Bazarbachi(American University of Beirut), Anne Huynh(Institut universitaire du cancer de Toulouse Oncopole), T Pagluica(King's College Hospital), Ibrahim Yakoub‐Agha(Inserm), Florent Malard(Sorbonne Université), Erik Aerts(University Hospital Zurich), Arnon Nagler(Sheba Medical Center), A.S. Alaskar(King Saud bin Abdulaziz University for Health Sciences), Michaël Abécassis(University of Arizona), Mauricette Michallet(Université Claude Bernard Lyon 1), Rafael F. Duarte(Institut Català d'Oncologia), Selim Corbacioglu(Unknown), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Tamás Masszi, Bipin N. Savani(Vanderbilt University Medical Center), F Baron(University of Liège), F. Bonde Petersen, PG Richardson(Dana-Farber Cancer Institute), Takahiro Fukuda(Takarazuka City Hospital), Mutlu Arat(Istanbul Florence Nightingale Hospital)
Cited by 387
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k